Recent research focusing on Semaglutide at a dosage of 30mg is shedding new light on its potential applications. Early findings suggest that this higher dosage may boost the drug's ability to manage blood sugar, potentially offering more significant outcomes for individuals with insulin resistance. Further study is underway to fully evaluate the lo